Executive Summary: New research published in the Journal of Stroke confirms that cannabis, cocaine, and amphetamines significantly elevate the risk of both ischemic and hemorrhagic strokes. By utilizing Mendelian randomization (MR), researchers have established that genetic liability to substance use disorders (SUD) plays a causal role in vascular pathology, marking a critical shift in how clinicians must evaluate modifiable stroke risk factors.
Comparative Stroke Risk by Substance Exposure
The following table summarizes the pooled odds ratios and risk increases for various illicit substances as identified in the meta-analysis of 100 million participants.
| Substance Type | General Stroke Risk Increase | Ischemic Stroke (OR) | Hemorrhagic Stroke (OR) |
|---|---|---|---|
| Cannabis | ~37% Increase | 1.39 | N/A (Heterogeneous) |
| Cocaine | ~Double Risk | ~2.00 | ~2.00 |
| Amphetamines | Markedly Higher | 2.37 | 2.83 |
| Opioids | Inconclusive | Low (Recent use only) | No Association |
Genetic Liability and the Causality Frontier
While previous epidemiological studies have noted correlations between drug use and stroke, this study utilized Mendelian randomization (MR) to explore causality. By analyzing genetic variants associated with substance use disorder (SUD) and cannabis use disorder (CUD), researchers found that genetic liability to these conditions predates the stroke outcomes, suggesting a direct causal pathway.
The MR analysis revealed that variants linked to a broad SUD predicted a 33% higher risk of any stroke and a staggering eight-fold risk of intracerebral hemorrhage. Specifically, cannabis use disorder was linked to an 11% increase in any stroke and a 35% increase in large-artery stroke. For cocaine dependence, the genetic data showed a 38% increase in the risk of intracerebral hemorrhage, further solidifying the drug's reputation as a primary driver of brain bleeds.
Vascular Mechanisms: Hypertension and Vasospasm
The biological plausibility of these findings lies in the acute physiological effects of the substances. Cannabis, cocaine, and amphetamines are known to induce hypertension and cerebral vasospasm, often triggered by sympathetic nervous system activation. Cannabis, in particular, has been shown to stimulate platelet aggregation, which explains its strong association with ischemic stroke (clot-based) rather than hemorrhagic events.
In younger cohorts (under 55 years of age), the risk patterns remained consistent. The study emphasizes that these drugs are not merely associated with "risky lifestyles" but are independent drivers of vascular damage. Cocaine was specifically identified as a catalyst for cardioembolic stroke, where blood clots formed in the heart travel to block cerebral arteries.
Alcohol and Nicotine: The Legal Substance Comparison
The study also provided comparative data on legal substances. Problematic alcohol use (PAU) was found to double the risk of large-artery stroke and increase the risk of cardioembolic stroke by 50%. Interestingly, in this specific genetic liability model, nicotine dependence did not show a direct causal change in stroke risk, though researchers noted that this does not negate the well-documented risks of combustible tobacco use.
Expert Verdict: A Public Health Imperative
As stroke remains the third leading cause of death and disability worldwide, identifying modifiable risk factors is essential. This meta-analysis, the most comprehensive to date, establishes that substance use disorders are a significant and often overlooked catalyst for vascular disease. From a clinical perspective, these findings suggest that prevention strategies targeting substance misuse must be integrated into broader stroke mitigation programs. For the 18–55 demographic, where drug-related stroke risk is at its peak, the data serves as a critical warning: the vascular cost of intoxication is both measurable and, in many cases, permanent.
- Journal reference: Ritson, M., Markus, H. S., & Harshfield, E. L. (2026). Does illicit drug use increase stroke risk? A systematic review, meta-analyses, and Mendelian randomization analysis. International Journal of Stroke. DOI: https://doi.org/10.1177/17474930261418926.https://journals.sagepub.com/doi/10.1177/17474930261418926
